NCT01530659: A trial that was reported late by Neurotech Pharmaceuticals
This trial has reported, although it was 660 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01530659 |
|---|---|
| Title | Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2012 |
| Completion date | July 1, 2019 |
| Required reporting date | June 30, 2020, midnight |
| Actual reporting date | April 22, 2022 |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | 660 |